ArticleInternational journal of molecular sciences2026
MFF-AE: Enhanced Quality Control for Proteomics Mass Spectrometry Data via Multi-Scale Feature Fusion.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mass spectrometry (MS) is a core analytical tool in proteomics, and the quality of the generated data directly determines the effectiveness of downstream analyses and the reliability of final research conclusions. While MS is also widely used in other omics applications, this study focuses on label-free quantitative proteomics, where samples are represented as protein-abundance matrices derived from MaxQuant. However, MS data are typically characterized by high dimensionality and substantial noise, posing serious challenges for quality control (QC). Existing QC methods have limited feature extraction capabilities and struggled to capture the key information embedded in the data, resulting in poor performance in identifying anomalous samples. Here, we propose the Multi-Scale Feature Fusion-based Autoencoder (MFF-AE). This deep learning-based anomaly detection model achieves precise identification of anomalous samples by integrating both global and local data features. The model consists of three modules: an autoencoder-based backbone network that efficiently embeds raw data into a low-dimensional semantic space, a local feature extraction and fusion module designed to capture and integrate multi-scale features within MS data, and a sample identification module that enhances discriminative representations to enable accurate anomaly detection. To evaluate the effectiveness of the proposed model, we conduct extensive experiments on a benchmark dataset with synthesized anomalies. Quantitative results on the benchmark dataset show that, compared with 15 baseline models from statistical learning, deep learning, and ensemble learning, our model consistently achieves the best performance across key metrics. Furthermore, through linear relationship analysis on real-world clinical datasets, the exclusion of outlier samples significantly increased the statistical significance and fold change in the identified differential proteins. Overall, the proposed model establishes a solid data foundation, paving the way for downstream mechanistic studies and target discovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.